CliffBio
small molecule

DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM

DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameDROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
Active ingredientDROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
Strength3MG,N/A;0.02MG,N/A;0.451MG,0.451MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 2018
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.